Literature DB >> 3209331

Validity of claims to lifelong non-smoking at age 36 in a longitudinal study.

N Britten1.   

Abstract

Consistency of self-reported cigarette smoking habits was investigated in the MRC National Survey of Health and Development, using data collected at ages 20, 25, 31 and 36 years. Of those claiming to be lifelong non-smokers at age 36, 7.9% had previously reported smoking at least one cigarette a day. Those cohort members with inconsistent records had smoked fewer cigarettes and were less likely to inhale than cohort members who smoked at age 36, and had started smoking later. Re-analysis of data collected by Friedman et al suggested that the effect of misclassification of ex-smokers was to reduce the relative risk of death from all causes, for men and women aged 35-54 years, by a factor of 5%. It is suggested that in future studies, those claiming to be lifelong non-smokers should be questioned about their habits in late adolescence and early adulthood.

Entities:  

Mesh:

Year:  1988        PMID: 3209331     DOI: 10.1093/ije/17.3.525

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  3 in total

1.  Effects of changes in smoking status on risk estimates for myocardial infarction among women recruited for the Royal College of General Practitioners' Oral Contraception Study in the UK.

Authors:  V Owen-Smith; P C Hannaford; M Warskyj; S Ferry; C R Kay
Journal:  J Epidemiol Community Health       Date:  1998-07       Impact factor: 3.710

2.  Exposure misclassification bias in studies of environmental tobacco smoke and lung cancer.

Authors:  A H Wu
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

3.  Characterisation of smoking behaviour across the life course and its impact on decline in lung function and all-cause mortality: evidence from a British birth cohort.

Authors:  S Clennell; D Kuh; J M Guralnik; K V Patel; G D Mishra
Journal:  J Epidemiol Community Health       Date:  2008-05-01       Impact factor: 3.710

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.